candesartan cilexetil and o-(chloroacetylcarbamoyl)fumagillol

candesartan cilexetil has been researched along with o-(chloroacetylcarbamoyl)fumagillol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Akagi, T; Egami, K; Ikeda, H; Imaizumi, T; Ishii, M; Matsuishi, T; Murohara, T; Sasaki, K; Shimada, T; Shintani, S; Sugaya, T1

Other Studies

2 other study(ies) available for candesartan cilexetil and o-(chloroacetylcarbamoyl)fumagillol

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth.
    The Journal of clinical investigation, 2003, Volume: 112, Issue:1

    Topics: Animals; Benzimidazoles; Biphenyl Compounds; Cyclohexanes; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Lymphokines; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; O-(Chloroacetylcarbamoyl)fumagillol; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sesquiterpenes; Tetrazoles; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003